Rani Therapeutics Holdings (RANI) Current Leases (2022 - 2026)

Rani Therapeutics Holdings' Current Leases history runs 5 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• On a quarterly basis, Current Leases rose 10.19% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 10.19% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 8.7% from the prior year.
• Current Leases fell to $1.5 million in Q1 2026 per RANI's latest filing, from $1.6 million in the prior quarter.
• Across five years, Current Leases topped out at $1.6 million in Q4 2025 and bottomed at $650000.0 in Q1 2022.
• The 5-year median for Current Leases is $1.0 million (2025), against an average of $1.1 million.
• Across the five-year window, Current Leases slipped 28.63% in 2023 and soared 103.2% in 2024, its largest moves.
• Year by year, Current Leases stood at $1.0 million in 2022, then declined by 28.63% to $718000.0 in 2023, then surged by 103.2% to $1.5 million in 2024, then advanced by 8.7% to $1.6 million in 2025, then decreased by 7.94% to $1.5 million in 2026.
• Per Business Quant, the three latest RANI Current Leases figures stand at $1.5 million (Q1 2026), $1.6 million (Q4 2025), and $1.0 million (Q3 2025).